V106F (p.Val106Phe) variant of ATP7B (Copper-transporting ATPase 2)
V106F (p.Val106Phe) in ATP7B (Copper-transporting ATPase 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.53 / 1. The record also includes structural context.
V106F (p.Val106Phe) variant details
- p.Val106Phe
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.533
- ESM-1b 0.78
- AlphaMissense 0.10
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available